MedMen, the California-based multistate cannabis operator, said it will receive an investment of up to $250 million from private equity fund Gotham Green Partners (GGP).
The investment – a convertible credit facility – is believed to be the largest to date by a single investor in a publicly traded cannabis company with U.S. operations.
The money will go toward a number of corporate activities including potential acquisitions, investment in technology and increased cultivation and production, MedMen said.
“More than having adequate growth capital to fund all of their current operational needs (and eliminating the lingering overhang of future tag on offerings), we believe the GGP investment comes with many lateral strategic benefits, as they are the preeminent investor across the cannabis supply chain,” Paul Penney, managing director at Northland Securities, told Marijuana Business Daily in an email.
MedMen stock (CSE: MMEN) was up more than 6% over its price at close the prior day on the Canadian Securities Exchange following the news.
Click here for more details via the company’s announcement.